Related Experiment Video
Updated: Apr 29, 2026

Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
Impact of Buccotherm® on xerostomia: a single blind study
Esin Alpöz1, Hülya Çankaya, Pelin Güneri
1Ege University Faculty of Dentistry, Department of Oral and Maxillofacial Radiology, Bornova/Izmir, Turkey.
Objective:
The purpose of this single blind study was to investigate effects of Buccotherm® spray on subjective symptoms of xerostomia patients.
Methods:
Twenty patients with dry mouth complaint were instructed to use placebo six times a day for 2 weeks. After a wash period, mineral water spray was provided. Patients were asked to reply questions regarding dry mouth using visual analog scale (VAS). Baseline and subsequent subjective findings on 1 hour after the application of the materials at the end of 1st, 7th, and 14th days were recorded.
Results:
At the end of 14-day treatment, no statistically significant differences were observed between the efficacy of placebo and commercial mineral water dental spray (p > 0.05). The VAS scores revealed that difficulty in mastication (p = 0.006), difficulty in swallowing (p = 0.00), need to sip liquids while eating (p = 0.000), difficulty in speech (p = 0.003), and waking up at night to sip water (p = 0.005) were statistically lower for placebo than commercial mineral water spray.
Conclusion:
The commercial mineral water dental spray was not more efficient than placebo in the management of dry mouth-related symptoms.
Clinical Relevance:
This study emphasizes the fundamental role of saliva in oral health and evaluates the clinical utility of a commercial dental spray.
More Related Videos
09:10Murine Salivary Functional Assessment via Pilocarpine Stimulation Following Fractionated Radiation
Published on: May 4, 2018
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Blind Procedures
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Bioavailability Study Design: Single Versus Multiple Dose Studies